Allianz Asset Management

Allianz Asset Management’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History

Allianz Asset Management’s Portfolio CORV Stock Details CORV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-20,000	Closed	-$185K	–	2559
2015 Q1	$185K	Hold	20,000	–	–	﹤0.01%	2203
2014 Q4	$185K	Hold	20,000	–	–	﹤0.01%	2199
2014 Q3	$179K	Hold	20,000	–	–	﹤0.01%	2175
2014 Q2	$157K	Hold	20,000	–	–	﹤0.01%	1825
2014 Q1	$158K	Buy	+20,000	New	+$161K	﹤0.01%	1803

Other funds holding CORV

Westfield Capital Management

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Clough Capital Partners Boston, Massachusetts $1.04B AUM 49.7% 1-Year Est. Return

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

AlphaOne Investment Services West Chester, Pennsylvania $79.4M AUM 49.42% 1-Year Est. Return

Turner Investments Berwyn, Pennsylvania $134K AUM 49.03% 1-Year Est. Return

Adage Capital Partners

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

PointState Capital New York $4.31B AUM 42.31% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return